Trial intelligence / Profile preview

Ninjinyoeito for fatigue in frail patients (eF3 Study)

jRCTs041180058Completed

Sponsor
Tsumura & Co.
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ninjinyoeito in asthenia and Fragility (2 arms), sponsored by Tsumura & Co. Primary endpoint: Fatigue (Chalder's fatigue scale at 24 weeks). Started Feb 2019; status: completed.

02

Drugs

ninjinyoeito
03

Conditions

astheniaFragility

Beyond the preview

Go deeper on jRCTs041180058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041180058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call